e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Performance of the BODE index in patients with ?1-antitrypsin deficiency-related COPD
Thabut Gabriel, Mornex Jean-François, Pison Christophe, Cuvelier Antoine, Balduyck Malika, Pujazon Marie-Christine, Fournier Michel, AitIlalne Brahim, Porcher Raphaël
Source:
Eur Respir J 2014; 44: 78-86
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Thabut Gabriel, Mornex Jean-François, Pison Christophe, Cuvelier Antoine, Balduyck Malika, Pujazon Marie-Christine, Fournier Michel, AitIlalne Brahim, Porcher Raphaël. Performance of the BODE index in patients with ?1-antitrypsin deficiency-related COPD. Eur Respir J 2014; 44: 78-86
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Can we assess COPD comorbidities by BODE index?
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Association between Frailty Index and BODE index with lung function and mortality in COPD
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
Pulmonary rehabilitation effects on BODE index in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 70s
Year: 2006
The BODE index in patient with COPD in Russia
Source: Eur Respir J 2007; 30: Suppl. 51, 78s
Year: 2007
Functional tests and relation to BODE index in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Assessment of functional status
Year: 2009
BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?
Source: International Congress 2014 – Clinical presentations
Year: 2014
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
What is the best predictor of mortality in chronic obstructive pulmonary disease? (BODE index and CPET)
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Relationship between quality of life and BODE index of stable ex-smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Higher BODE Index in COPD patients correlated with higher number of comorbidities
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
Comorbidities in COPD patients – their prevalence and correlation with BODE index
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Karnofsky index as predictor of exacerbations in moderate and severe COPD patients
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Multidimensional system for assessment of COPD patients. Comparison with BODE index
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005
Assessment of relation between BODE index and quality of life, nutritional status, and C-reactive protein in patients with COPD
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007
Relationship between BODE-index and quality of life in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 56s
Year: 2005
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
The modified BODE index: validation with mortality in COPD
Source: Eur Respir J 2008; 32: 1269-1274
Year: 2008
Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
The clinical importance of centrilobular enfisema in COPD patients: its impact on the BODE index.
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept